# Abnormal Cardiac Autonomic Regulation in Mice Lacking ASIC3

Authors: Ching-Feng Cheng; Terry B. J. Kuo; Wei-Nan Chen; Chao-Chieh Lin; Chih-Cheng Chen
Journal: BioMed Research International
 (2014)

---

## Abstract

Integration of sympathetic and parasympathetic outflow is essential in maintaining normal cardiac autonomic function. Recent studies demonstrate that acid-sensing ion channel 3 (ASIC3) is a sensitive acid sensor for cardiac ischemia and prolonged mild acidification can open ASIC3 and evoke a sustained inward current that fires action potentials in cardiac sensory neurons. However, the physiological role of ASIC3 in cardiac autonomic regulation is not known. In this study, we elucidate the role of ASIC3 in cardiac autonomic function usingAsic3
−/− mice. Asic3
−/− mice showed normal baseline heart rate and lower blood pressure as compared with their wild-type littermates. Heart rate variability analyses revealed imbalanced autonomic regulation, with decreased sympathetic function. Furthermore, Asic3
−/− mice demonstrated a blunted response to isoproterenol-induced cardiac tachycardia and prolonged duration to recover to baseline heart rate. Moreover, quantitative RT-PCR analysis of gene expression in sensory ganglia and heart revealed that no gene compensation for muscarinic acetylcholines receptors and beta-adrenalin receptors were found in Asic3
−/− mice. In summary, we unraveled an important role of ASIC3 in regulating cardiac autonomic function, whereby loss of ASIC3 alters the normal physiological response to ischemic stimuli, which reveals new implications for therapy in autonomic nervous system-related cardiovascular diseases.


---

## Body

## 1. Introduction

Acid-sensing ion channel 3 (ASIC3) is the most sensitive acid sensor (pH0.5 activation ~6.7) predominantly expressed in the peripheral sensory neurons [1, 2]. It can be activated by low extracellular pH to evoke both transient and sustained inward currents, which can be further enhanced by lactate [3, 4]. ASIC3 has been recognized as not only an acid sensor but also a metabolic sensor for lactic acid acidosis [4, 5]. The physiological significance of ASIC3 is emphasized by sensory neurons expressing ASIC3 or ASIC3-like currents innervating skin, heart, muscle, vessels, and many visceral tissues [5–12]. Because of its specific expression in sensory neurons and its property of proton-evoked sustained current, ASIC3 has attracted much attention in pain studies [13–15].Apart from the sensitivity to pH drop and lactic acid, the expression of ASIC3 is highly specific to sensory neurons [3, 16]. Since those neurons are composed of major cardiac afferents, ASIC3 may help to transduce angina, the chest pain that accompanies cardiac ischemia [17]. This is supported by studies showing that ASIC3 reproduces the functional features of cardiac ischemia-sensing neurons [7, 18]. During angina, the sympathetic division can further trigger a counterproductive sympathetic reflex that causes stronger and faster contraction in response to insufficient oxygen [19]. Although the balance of autonomic nervous control has been considered a key factor in maintaining normal cardiac function, descriptions of the sensory inputs and reflex regulation of the autonomic nervous system are rare. Recent report also described that overexpression of ASIC3 channel in carotid body glomus cells could activate sympathetic nervous activity and induce prehypertension state in young spontaneously hypertensive rat (SHR) and ASIC3 is one of the major components to form pH-sensitive channel in mouse cardiac dorsal root ganglion neurons, implying a significant role of ASIC3 regulating autonomic function [20, 21]. Accordingly, we sought to further explore thein vivo role of ASIC3 in modulating the cardiac autonomic nervous system in conscious mice, since cardiac autonomic function has been suggested to reveal the healthy condition of humans. The spectral analysis in detecting heart rate variability (HRV) through electrocardiography (ECG) has enhanced the study of the sympathetic and parasympathetic function of patients and has been subsequently applied inin vivo animal studies [22]. Therefore, we used HRV and ECGin vivoanalysis ofAsic3 knockout (Asic3
−/−) mice to unravel a role of ASIC3 in regulation of cardiac autonomic function.


## 2. Methods

### 2.1. Animals

Mice were raised in a 12 h light/12 h dark cycle (08:00–20:00 lights on) at 21°C and 40% to 70% humidity. All experiments involved male mice aged 8 to 12 weeks. Telemetric surgery was performed at 12 weeks, and ECG was initiated 1 week after the operation.Asic3
−/− mice were generated as previously described [23]. Congenic 129 heterozygous (Asic3
+/−) mice were derived by breedingAsic3 chimera with females of 129S2/SvPasCrl wild types (Asic3
+/+), the same mouse strain as from the embryonic stem cells we used.Asic3
+/+ andAsic3
−/− mice were offspring of the congenicAsic3
+/− mice intercross. Mouse genotyping was by PCR. For theAsic3
−/− allele, we used the primers 5′-ATTCAGGCTGCGCAACTGTT-3′ and 5′-TGTGGTCCCAGGACTTGGTA-3′ and forAsic3
+/+ 5′-CACAGCTCCAGGAGGAGTTGAA-3′ and 5′-CCTTGTGACGAGGTAACAGGTA-3′. The animals were bred and cared for in accordance with the currentGuide for the Use of Laboratory Animals (National Academy Press, Washington DC). The experimental protocols were approved by the local animal use committee (IACUC, Academia Sinica).


### 2.2. Blood Pressure

Systolic blood pressure and heart rate (HR) in the conscious state were measured by use of a blood pressure monitor for mice and rats, Model MK-2000 (Muromachi Kikai, Tokyo, Japan), according to the manufacturer’s instructions. Diastolic blood pressure was calculated from the systolic blood pressure and mean blood pressure.


### 2.3. Animal Preparation for Radiotelemetry Study

For ambulatory long-term ECG analysis in the conscious state, a telemetry transmitter (TA10EA-F20, Data Sciences; St. Paul, MN) was implanted inAsic3
−/− mice (N
=
16) and correspondingAsic3
+/+ mice (N
=
15). Mice were anesthetized with pentobarbital (58.5 mg/kg, given intraperitoneally) and the transmitter was positioned in the abdominal cavity and sutured to the inside of the muscle wall. After surgery, mice were given antibiotics (1% chlortetracycline) and housed individually for recovery for at least 7 days. To allow the mice to habituate to the experimental apparatus, each animal in the home cage was placed in the recording environment for 2 h for at least 2 sequential days before being tested. For each recording, animals in their home cages were first brought to the top of the recording plates for 30 min to allow them to become familiar with the situation. ECG was then performed for 2 h (14:00–16:00) in an isolated room. For induced cardiac ischemia, isoproterenol (1.5 mg/kg) was administered intraperitoneally (N
=
7 of both genotypes).


### 2.4. HRV Studies in Frequency Domain Measure

ECG signals were converted to digitized signals by use of an analog-to-digital converter. Digital signal processing of the bioelectric signals was modified from our previous algorithm designed for humans and rats [24, 25]. Preprocessing of the ECG signals followed the recommended procedure [26]. In brief, the computer algorithm identified each QRS complex and rejected each ventricular premature complex or noise according to its likelihood in a standard QRS template. Stationary R-R intervals (RR) were resampled and interpolated at a rate of 64 Hz to provide continuity in the time domain. A Hamming window was applied to each time segment to attenuate the leakage effect. Our algorithm then estimated the power density of the spectral components from fast Fourier transform. The resulting power spectrum was corrected for attenuation resulting from sampling and the Hamming window. Each component of the spectrogram was subsequently quantified by the method of integration. Three different frequency domain measures of HRV were computed. Cut-off frequencies for power in the low frequency (LF) and high frequency (HF) ranges were based on those previously reported for mice with 129 backgrounds and defined as 0.25–1.00 Hz and 1.00–6.00 Hz, respectively. Total power (TP) frequency was defined as 0.00–8.5 Hz. LF and HF were also measured in normalized units, which represent the relative value of each power component in proportion to the sum of the LF and HF components. LF, HF, and LF : TP ratio of the RR spectrogram were quantified and logarithmically transformed to correct for the skewness of the distribution [27].


### 2.5. Data Collection and Statistics

Because HR and HRV were highly variable between sleeping and awake states in mice, we only analyzed ECG data from the resting state for baseline activity in a 1 min base. ECG results from minutes 1, 6, 11, 16, and so forth were selected, if no movement occurred. Otherwise, the 1 min data were skipped and next acceptable data was used. At maximum, a total of 10 points were collected from 2 h ECG for HR and HRV in each mouse. For resident-intruder tests, we analyzed ECG data in a 30 s base, except for the period of attack. We collected ECG data from each attack lasting more than 2 s. We used one-way ANOVA for all statistical analysis. Data are presented as means ± SEM. AP
<
0.05 was considered significant.


### 2.6. Real-Time Quantitative RT-PCR

DRG (C8-T3), nodose ganglia, and hearts were dissected from mice of both genotypes. RNA was isolated from a single ganglion homogenized in a 1.5 mL tube with use of a plastic pestle and lysis buffer and purified by use of the RNeasy mini kit (Qiagen). Heart RNA was isolated with Trizol according to the manufacturer’s instructions (Invitrogen). RNA was treated with DNase I (4 U/μg) for 20 min at room temperature. Total RNA of a ganglion (300 ng) or heart (650 ng) was reverse-transcribed by Superscript III RT (Invitrogen). One microliter of derived cDNA (approximately 2 ng) was used as a template for real-time quantitative SYBR Green I PCR carried out in the ABI Prism 7700 Sequence Detection System as the manufacturer’s instruction (PE Applied Biosystems). The threshold cycle (CT) value indicated the fractional cycle numbers at which the amount of amplified target reached a fixed threshold. The CT values of both the target and the internal reference (GAPDH or cyclophilin) were measured from the same samples, and the expression of the target gene relative to that of GAPDH or cyclophilin was calculated by the comparative CT method, which normalized the expression levels and allowed for calculation of the relative efficiency of the target and reference amplification. Primers used for real-time PCR were as follows: ASIC1a forward 5′-ACAAGGCCAACTTCCGTAGC-3′, reverse 5′-ACTTCCCATACCGCGTGAAG-3′; ASIC1b forward 5′-CCCCATGCTCGGGTTGGATG-3′, reverse 5′-TAGGAGCAATAGAGCAGCATG-3′; ASIC2a forward 5′-AAACCGAAGCAGTTCAGCATGCTG-3′, reverse 5′-GCCATCCTCGCCTGAGTTAAAC-3′; ASIC2b forward 5′-AGACAGTGGTTCCGCAAGCT-3′; ASIC3 forward 5′-TGCTCCAGGAAGAGTTGAATG-3′, and reverse 5′CCTTGTGACGAGGTAACAGGTA-3′; capsaicin receptor (TRPV1) forward 5′-TCTCCACTGGTGTTGAGACG-3′, reverse 5′-GGGTCTTTGAACTCGCTGTC-3′; GAPDH forward 5′-GGAGCCAAACGGGTCATCATCTC-3′, reverse 5′-GAGGGGCCATCCACAGTCTTCT-3′; cholinergic receptor muscarinic 1 (M1) forward 5′-AAGTGGCATTCATCGGGATCAC-3′, reverse 5′-GTTGTTGACTGTCTTGAGCTCTG-3′; cholinergic receptor muscarinic 1 (M2) forward 5′-GTGGACAATTGGCTACTGGCTC-3′, reverse 5′-CCTTGTAGCGCCTATGTTCTTG-3′; cholinergic receptor muscarinic 1 (M4) forward 5′-TGCCATCGAGATCGTACCTG-3′, reverse 5′-AGATTGTCCGAGTCACTTTGCG-3′; adrenergic receptor beta 1 (adrb1) forward 5′-CTACTCGTGGCGCTCATCGTT-3′, reverse 5′-AATCCCATGACCAGATCAGCGCT-3′; adrenergic receptor beta 2 (adrb2) forward 5′-TGGTGCGAGTTCTGGACTTCCA-3′, reverse 5′- GAAGGGCGATGTGATAGCAACA-3′; adrenergic receptor beta 3 (adrb3) forward 5′-CATAACCAACGTGTTCGTGACT-3′, reverse 5′-TGACGTCCACAGTTCGCAACCA-3′; and cyclophilin forward 5′-ACAGGTCCTGGCATCTTGTC-3′, reverse 5′-CATGGCTTCCACAATGTTCA-3′.


### 2.7. Western Blotting

Total proteins (100μg) were extracted from hearts of adult male mice. Samples were separated by SDS-PAGE (10% acrylamide) and transferred to PVDF membrane. Immunoblotting was performed with antibodies against β2 AR (dilution 1 : 100; Santa Cruz Biotechnology), m2-mAChR (1 : 250; Chemicon), and actin (1 : 5000; Sigma). Secondary antibody (1 : 5000) for β2 AR and m2-mAChR was anti-rabbit IgG conjugated with horseradish peroxidase (HRP) and that for actin was anti-mouse IgG conjugated with HRP (Chemicon). Bound antibodies were visualized on enhanced chemiluminescence according to the manufacturer’s instructions. Antibodies were diluted in 50 mM Tris, pH 7.5, and 0.2 M NaCl containing 1% bovine serum albumin and 0.05% Tween 20.


## 2.1. Animals

Mice were raised in a 12 h light/12 h dark cycle (08:00–20:00 lights on) at 21°C and 40% to 70% humidity. All experiments involved male mice aged 8 to 12 weeks. Telemetric surgery was performed at 12 weeks, and ECG was initiated 1 week after the operation.Asic3
−/− mice were generated as previously described [23]. Congenic 129 heterozygous (Asic3
+/−) mice were derived by breedingAsic3 chimera with females of 129S2/SvPasCrl wild types (Asic3
+/+), the same mouse strain as from the embryonic stem cells we used.Asic3
+/+ andAsic3
−/− mice were offspring of the congenicAsic3
+/− mice intercross. Mouse genotyping was by PCR. For theAsic3
−/− allele, we used the primers 5′-ATTCAGGCTGCGCAACTGTT-3′ and 5′-TGTGGTCCCAGGACTTGGTA-3′ and forAsic3
+/+ 5′-CACAGCTCCAGGAGGAGTTGAA-3′ and 5′-CCTTGTGACGAGGTAACAGGTA-3′. The animals were bred and cared for in accordance with the currentGuide for the Use of Laboratory Animals (National Academy Press, Washington DC). The experimental protocols were approved by the local animal use committee (IACUC, Academia Sinica).


## 2.2. Blood Pressure

Systolic blood pressure and heart rate (HR) in the conscious state were measured by use of a blood pressure monitor for mice and rats, Model MK-2000 (Muromachi Kikai, Tokyo, Japan), according to the manufacturer’s instructions. Diastolic blood pressure was calculated from the systolic blood pressure and mean blood pressure.


## 2.3. Animal Preparation for Radiotelemetry Study

For ambulatory long-term ECG analysis in the conscious state, a telemetry transmitter (TA10EA-F20, Data Sciences; St. Paul, MN) was implanted inAsic3
−/− mice (N
=
16) and correspondingAsic3
+/+ mice (N
=
15). Mice were anesthetized with pentobarbital (58.5 mg/kg, given intraperitoneally) and the transmitter was positioned in the abdominal cavity and sutured to the inside of the muscle wall. After surgery, mice were given antibiotics (1% chlortetracycline) and housed individually for recovery for at least 7 days. To allow the mice to habituate to the experimental apparatus, each animal in the home cage was placed in the recording environment for 2 h for at least 2 sequential days before being tested. For each recording, animals in their home cages were first brought to the top of the recording plates for 30 min to allow them to become familiar with the situation. ECG was then performed for 2 h (14:00–16:00) in an isolated room. For induced cardiac ischemia, isoproterenol (1.5 mg/kg) was administered intraperitoneally (N
=
7 of both genotypes).


## 2.4. HRV Studies in Frequency Domain Measure

ECG signals were converted to digitized signals by use of an analog-to-digital converter. Digital signal processing of the bioelectric signals was modified from our previous algorithm designed for humans and rats [24, 25]. Preprocessing of the ECG signals followed the recommended procedure [26]. In brief, the computer algorithm identified each QRS complex and rejected each ventricular premature complex or noise according to its likelihood in a standard QRS template. Stationary R-R intervals (RR) were resampled and interpolated at a rate of 64 Hz to provide continuity in the time domain. A Hamming window was applied to each time segment to attenuate the leakage effect. Our algorithm then estimated the power density of the spectral components from fast Fourier transform. The resulting power spectrum was corrected for attenuation resulting from sampling and the Hamming window. Each component of the spectrogram was subsequently quantified by the method of integration. Three different frequency domain measures of HRV were computed. Cut-off frequencies for power in the low frequency (LF) and high frequency (HF) ranges were based on those previously reported for mice with 129 backgrounds and defined as 0.25–1.00 Hz and 1.00–6.00 Hz, respectively. Total power (TP) frequency was defined as 0.00–8.5 Hz. LF and HF were also measured in normalized units, which represent the relative value of each power component in proportion to the sum of the LF and HF components. LF, HF, and LF : TP ratio of the RR spectrogram were quantified and logarithmically transformed to correct for the skewness of the distribution [27].


## 2.5. Data Collection and Statistics

Because HR and HRV were highly variable between sleeping and awake states in mice, we only analyzed ECG data from the resting state for baseline activity in a 1 min base. ECG results from minutes 1, 6, 11, 16, and so forth were selected, if no movement occurred. Otherwise, the 1 min data were skipped and next acceptable data was used. At maximum, a total of 10 points were collected from 2 h ECG for HR and HRV in each mouse. For resident-intruder tests, we analyzed ECG data in a 30 s base, except for the period of attack. We collected ECG data from each attack lasting more than 2 s. We used one-way ANOVA for all statistical analysis. Data are presented as means ± SEM. AP
<
0.05 was considered significant.


## 2.6. Real-Time Quantitative RT-PCR

DRG (C8-T3), nodose ganglia, and hearts were dissected from mice of both genotypes. RNA was isolated from a single ganglion homogenized in a 1.5 mL tube with use of a plastic pestle and lysis buffer and purified by use of the RNeasy mini kit (Qiagen). Heart RNA was isolated with Trizol according to the manufacturer’s instructions (Invitrogen). RNA was treated with DNase I (4 U/μg) for 20 min at room temperature. Total RNA of a ganglion (300 ng) or heart (650 ng) was reverse-transcribed by Superscript III RT (Invitrogen). One microliter of derived cDNA (approximately 2 ng) was used as a template for real-time quantitative SYBR Green I PCR carried out in the ABI Prism 7700 Sequence Detection System as the manufacturer’s instruction (PE Applied Biosystems). The threshold cycle (CT) value indicated the fractional cycle numbers at which the amount of amplified target reached a fixed threshold. The CT values of both the target and the internal reference (GAPDH or cyclophilin) were measured from the same samples, and the expression of the target gene relative to that of GAPDH or cyclophilin was calculated by the comparative CT method, which normalized the expression levels and allowed for calculation of the relative efficiency of the target and reference amplification. Primers used for real-time PCR were as follows: ASIC1a forward 5′-ACAAGGCCAACTTCCGTAGC-3′, reverse 5′-ACTTCCCATACCGCGTGAAG-3′; ASIC1b forward 5′-CCCCATGCTCGGGTTGGATG-3′, reverse 5′-TAGGAGCAATAGAGCAGCATG-3′; ASIC2a forward 5′-AAACCGAAGCAGTTCAGCATGCTG-3′, reverse 5′-GCCATCCTCGCCTGAGTTAAAC-3′; ASIC2b forward 5′-AGACAGTGGTTCCGCAAGCT-3′; ASIC3 forward 5′-TGCTCCAGGAAGAGTTGAATG-3′, and reverse 5′CCTTGTGACGAGGTAACAGGTA-3′; capsaicin receptor (TRPV1) forward 5′-TCTCCACTGGTGTTGAGACG-3′, reverse 5′-GGGTCTTTGAACTCGCTGTC-3′; GAPDH forward 5′-GGAGCCAAACGGGTCATCATCTC-3′, reverse 5′-GAGGGGCCATCCACAGTCTTCT-3′; cholinergic receptor muscarinic 1 (M1) forward 5′-AAGTGGCATTCATCGGGATCAC-3′, reverse 5′-GTTGTTGACTGTCTTGAGCTCTG-3′; cholinergic receptor muscarinic 1 (M2) forward 5′-GTGGACAATTGGCTACTGGCTC-3′, reverse 5′-CCTTGTAGCGCCTATGTTCTTG-3′; cholinergic receptor muscarinic 1 (M4) forward 5′-TGCCATCGAGATCGTACCTG-3′, reverse 5′-AGATTGTCCGAGTCACTTTGCG-3′; adrenergic receptor beta 1 (adrb1) forward 5′-CTACTCGTGGCGCTCATCGTT-3′, reverse 5′-AATCCCATGACCAGATCAGCGCT-3′; adrenergic receptor beta 2 (adrb2) forward 5′-TGGTGCGAGTTCTGGACTTCCA-3′, reverse 5′- GAAGGGCGATGTGATAGCAACA-3′; adrenergic receptor beta 3 (adrb3) forward 5′-CATAACCAACGTGTTCGTGACT-3′, reverse 5′-TGACGTCCACAGTTCGCAACCA-3′; and cyclophilin forward 5′-ACAGGTCCTGGCATCTTGTC-3′, reverse 5′-CATGGCTTCCACAATGTTCA-3′.


## 2.7. Western Blotting

Total proteins (100μg) were extracted from hearts of adult male mice. Samples were separated by SDS-PAGE (10% acrylamide) and transferred to PVDF membrane. Immunoblotting was performed with antibodies against β2 AR (dilution 1 : 100; Santa Cruz Biotechnology), m2-mAChR (1 : 250; Chemicon), and actin (1 : 5000; Sigma). Secondary antibody (1 : 5000) for β2 AR and m2-mAChR was anti-rabbit IgG conjugated with horseradish peroxidase (HRP) and that for actin was anti-mouse IgG conjugated with HRP (Chemicon). Bound antibodies were visualized on enhanced chemiluminescence according to the manufacturer’s instructions. Antibodies were diluted in 50 mM Tris, pH 7.5, and 0.2 M NaCl containing 1% bovine serum albumin and 0.05% Tween 20.


## 3. Results

### 3.1.Asic3
−/− Mice Showed Abnormal Autonomic Regulation in Heart Rate Variability and Blood Pressure

Asic3
−/− mice had anatomically normal hearts and were viable. To explore the role of ASIC3 in the regulation of autonomic nervous system-related cardiac activity without perturbation by handling or use of anesthetics, we used ambulatory radiotelemetry for ECG recording and HRV study and expressed values as power spectral density. Baseline ECG data were recorded for two consecutive days. We analyzed HR and HRV at resting status on day 2.Asic3
−/− mice showed normal HR on resting ECG as compared withAsic3
+/+ mice. On HRV analysis,Asic3
−/− mice showed normal HR and normal HF and TP spectral density as compared withAsic3
+/+ mice (Figure 1(a)). However,Asic3
−/− mice showed significantly lower ratios in LF power spectral density (LF%) thanAsic3
−/− mice. As compared with the resting status, in the stressed situation, bothAsic3
+/+ andAsic3
−/− mice increased HR during tail-cuff measurement of blood pressure (Figure 1(b)). Despite their increased HR,Asic3
−/− mice showed significantly lower blood pressure thanAsic3
+/+ mice under stress.Baseline cardiovascular activity in theAsic3
−/− mice. (a) Telemetric studies showed bothAsic3
+/+ andAsic3
−/− mice with similar baseline HR in resting status (501 ± 5 bpm versus 507 ± 4 bpm).Asic3
−/− mice exhibited lower LF% but normal HF and TP as compared withAsic3
+/+ mice (*P
<
0.05, N
=
15 forAsic3
+/+ and N
=
16 forAsic3
−/−). (b)Asic3
−/− mice showed significantly lower systolic, mean, diastolic blood pressure thanAsic3
+/+ mice (*P
<
0.05). The mean HR of consciousAsic3
−/− mice (N
=
13) was 570 ± 22 bpm and that ofAsic3
+/+ mice (N
=
13) was 596 ± 17 bpm.
(a)
(b)


### 3.2.Asic3
−/− Mice Showed Abnormal Response to Isoproterenol-Induced Tachycardia

Lastly, we wondered whether loss of ASIC3 had any effect on the myocardium under chemical stimulation such as cardiac ischemia. Isoproterenol is a potent-adrenergic agonist known to induce tachycardia and myocardial ischemia when given in high doses to rodents [28]. Both genotypes produced the expected ECG pattern of sinus tachycardia with a period of ST depression on isoproterenol treatment (Figure 2(a)). However,Asic3
−/− mice showed a blunted response to isoproterenol-induced tachycardia, with only subtle HR increment (mean RR interval 84.7
±
0.13 ms forAsic3
−/− versus 82.4
±
0.08 ms forAsic3
+/+ mice, Figure 2(b)) but prolonged duration to recover to baseline HR (defined as RR = 90 ms, Figure 2(c)).Isoproterenol-induced tachycardia (a) ECG of RR interval showing tachycardia from both genotypes 5 min after isoproterenol injection (1.5 mg/kg given intraperitoneally) on radiotelemetry.Asic3
+/+ mice showed higher HR thanAsic3
−/− mice in most periods of tachycardia (*P
<
0.05).Asic3
−/− mice needed a longer time to slow down the HR to baseline thanAsic3
+/+ mice. (b) Mean HR during isoproterenol-induced tachycardia is significantly different between genotypes; tachycardia defined as RR interval less than 90 ms;Asic3
−/− mice 84.7 ± 0.1 ms versusAsic3
+/+ mice 82.4 ± 0.1 ms. (c) Mean duration of isoproterenol-induced tachycardia ofAsic3
−/− mice 82.9 ± 5.1 min versusAsic3
+/+ mice 59.7 ± 1.7 min (**P
<
0.01, ***P
<
0.001; N
=
7
Asic3
+/+ mice; N
=
7
Asic3
−/− mice).
(a)
(b)
(c)


### 3.3. Differential Expression ofAsic3 andTrpv1 Transcripts in DRG and Nodose Ganglia

We compared the expression of two major peripheral acid-sensing molecules,Asic3 andTrpv1, in sympathetic and parasympathetic sensory ganglia in normal mice. Quantitative RT-PCR revealed DRG (C8 and T2) with a higher level ofAsic3 mRNA (4- to 8-fold) than nodose ganglia (Figure 3(a)). In contrast, the expression ofTrpv1 mRNA in nodose ganglia was higher (2- to 4-fold) than that in DRG. Moreover, the expression of otherAsic subtypes, such asAsic1a,Asic1b, andAsic2b, was higher in the sympathetic division than in the parasympathetic division. The expression ofTrpv1 in T2 DRG and nodose ganglia did not differ betweenAsic3
−/− andAsic3
+/+ mice (Figure 3(b)).Quantitative RT-PCR and Western blotting analyses of gene expression in sensory ganglia and heart. (a) The expression ofAsic1a,Asic1b,Asic2b, andAsic3 is significantly lower in nodose ganglia (4- to 8-fold, *P
<
0.05) than in DRG (C8 and T2), with the expression ofTrpv1 significantly higher in nodose ganglia than in DRG (*P
<
0.05). (b) The expression of TRPV1 did not significantly differ betweenAsic3
−/− andAsic3
+/+ mice in T2 DRG and nodose ganglia. (c) Gene expression of muscarinic acetylcholine receptors (M1, M2, and M4) and beta-adrenoceptors (adrb1,adrb2, andadrb3) not altered in hearts ofAsic3
−/− mice. (d) Protein levels of adrenoceptors (b2-AR) and acetylcholine receptors (m2-AchR2) not altered in hearts ofAsic3
−/− mice on western analysis. Expression of actin protein was used as an internal control. N
=
3
Asic3
+/+ mice and N
=
3
Asic3
−/− mice.
(a)
(b)
(c)
(d)


### 3.4.Asic3
−/− Mice Did Not Show Gene Compensation for Muscarinic Acetylcholine Receptors and Beta-Adrenalin Receptors in Hearts

Previously, Northern blot analysis onAsic1a,Asic1b,Asic2,Asic4,Trpv1, andTrpv2 genes was done inAsic3
−/− mice to determine whether theAsic3 null mutation interferes with the expression of members of the ASIC and TRPV gene families. Our results indicate that no compensatory changes of other ASIC subtypes and TRPV genes occurred in DRG ofAsic3
−/− mice [23]. We next needed to determine whether gene compensation in the heart accounted for the abnormal cardiac autonomic regulation and isoproterenol response inAsic3
−/− mice. Because muscarinic acetylcholine receptors and beta-adrenoceptors are responsible for autonomic activity, we compared their expression in the heart ofAsic3
−/− andAsic3
+/+ mice. The expression ofM1,M2, andM4, as well asadrb1,adrb2, andadrb3, did not significantly differ between the genotypes (Figure 3(c)). The expression ofM3 andM5 was not detectable in hearts ofAsic3
−/− orAsic3
+/+ mice. We further verified a similar protein expression ofadrb2 andM2 in hearts of the two genotypes (Figure 3(d)). Therefore, gene compensation was not found in theAsic3
−/− mice and these results support our hypothesis that ASIC3 has its unique role in cardiac autonomic regulation.


## 3.1.Asic3
−/− Mice Showed Abnormal Autonomic Regulation in Heart Rate Variability and Blood Pressure

Asic3
−/− mice had anatomically normal hearts and were viable. To explore the role of ASIC3 in the regulation of autonomic nervous system-related cardiac activity without perturbation by handling or use of anesthetics, we used ambulatory radiotelemetry for ECG recording and HRV study and expressed values as power spectral density. Baseline ECG data were recorded for two consecutive days. We analyzed HR and HRV at resting status on day 2.Asic3
−/− mice showed normal HR on resting ECG as compared withAsic3
+/+ mice. On HRV analysis,Asic3
−/− mice showed normal HR and normal HF and TP spectral density as compared withAsic3
+/+ mice (Figure 1(a)). However,Asic3
−/− mice showed significantly lower ratios in LF power spectral density (LF%) thanAsic3
−/− mice. As compared with the resting status, in the stressed situation, bothAsic3
+/+ andAsic3
−/− mice increased HR during tail-cuff measurement of blood pressure (Figure 1(b)). Despite their increased HR,Asic3
−/− mice showed significantly lower blood pressure thanAsic3
+/+ mice under stress.Baseline cardiovascular activity in theAsic3
−/− mice. (a) Telemetric studies showed bothAsic3
+/+ andAsic3
−/− mice with similar baseline HR in resting status (501 ± 5 bpm versus 507 ± 4 bpm).Asic3
−/− mice exhibited lower LF% but normal HF and TP as compared withAsic3
+/+ mice (*P
<
0.05, N
=
15 forAsic3
+/+ and N
=
16 forAsic3
−/−). (b)Asic3
−/− mice showed significantly lower systolic, mean, diastolic blood pressure thanAsic3
+/+ mice (*P
<
0.05). The mean HR of consciousAsic3
−/− mice (N
=
13) was 570 ± 22 bpm and that ofAsic3
+/+ mice (N
=
13) was 596 ± 17 bpm.
(a)
(b)


## 3.2.Asic3
−/− Mice Showed Abnormal Response to Isoproterenol-Induced Tachycardia

Lastly, we wondered whether loss of ASIC3 had any effect on the myocardium under chemical stimulation such as cardiac ischemia. Isoproterenol is a potent-adrenergic agonist known to induce tachycardia and myocardial ischemia when given in high doses to rodents [28]. Both genotypes produced the expected ECG pattern of sinus tachycardia with a period of ST depression on isoproterenol treatment (Figure 2(a)). However,Asic3
−/− mice showed a blunted response to isoproterenol-induced tachycardia, with only subtle HR increment (mean RR interval 84.7
±
0.13 ms forAsic3
−/− versus 82.4
±
0.08 ms forAsic3
+/+ mice, Figure 2(b)) but prolonged duration to recover to baseline HR (defined as RR = 90 ms, Figure 2(c)).Isoproterenol-induced tachycardia (a) ECG of RR interval showing tachycardia from both genotypes 5 min after isoproterenol injection (1.5 mg/kg given intraperitoneally) on radiotelemetry.Asic3
+/+ mice showed higher HR thanAsic3
−/− mice in most periods of tachycardia (*P
<
0.05).Asic3
−/− mice needed a longer time to slow down the HR to baseline thanAsic3
+/+ mice. (b) Mean HR during isoproterenol-induced tachycardia is significantly different between genotypes; tachycardia defined as RR interval less than 90 ms;Asic3
−/− mice 84.7 ± 0.1 ms versusAsic3
+/+ mice 82.4 ± 0.1 ms. (c) Mean duration of isoproterenol-induced tachycardia ofAsic3
−/− mice 82.9 ± 5.1 min versusAsic3
+/+ mice 59.7 ± 1.7 min (**P
<
0.01, ***P
<
0.001; N
=
7
Asic3
+/+ mice; N
=
7
Asic3
−/− mice).
(a)
(b)
(c)


## 3.3. Differential Expression ofAsic3 andTrpv1 Transcripts in DRG and Nodose Ganglia

We compared the expression of two major peripheral acid-sensing molecules,Asic3 andTrpv1, in sympathetic and parasympathetic sensory ganglia in normal mice. Quantitative RT-PCR revealed DRG (C8 and T2) with a higher level ofAsic3 mRNA (4- to 8-fold) than nodose ganglia (Figure 3(a)). In contrast, the expression ofTrpv1 mRNA in nodose ganglia was higher (2- to 4-fold) than that in DRG. Moreover, the expression of otherAsic subtypes, such asAsic1a,Asic1b, andAsic2b, was higher in the sympathetic division than in the parasympathetic division. The expression ofTrpv1 in T2 DRG and nodose ganglia did not differ betweenAsic3
−/− andAsic3
+/+ mice (Figure 3(b)).Quantitative RT-PCR and Western blotting analyses of gene expression in sensory ganglia and heart. (a) The expression ofAsic1a,Asic1b,Asic2b, andAsic3 is significantly lower in nodose ganglia (4- to 8-fold, *P
<
0.05) than in DRG (C8 and T2), with the expression ofTrpv1 significantly higher in nodose ganglia than in DRG (*P
<
0.05). (b) The expression of TRPV1 did not significantly differ betweenAsic3
−/− andAsic3
+/+ mice in T2 DRG and nodose ganglia. (c) Gene expression of muscarinic acetylcholine receptors (M1, M2, and M4) and beta-adrenoceptors (adrb1,adrb2, andadrb3) not altered in hearts ofAsic3
−/− mice. (d) Protein levels of adrenoceptors (b2-AR) and acetylcholine receptors (m2-AchR2) not altered in hearts ofAsic3
−/− mice on western analysis. Expression of actin protein was used as an internal control. N
=
3
Asic3
+/+ mice and N
=
3
Asic3
−/− mice.
(a)
(b)
(c)
(d)


## 3.4.Asic3
−/− Mice Did Not Show Gene Compensation for Muscarinic Acetylcholine Receptors and Beta-Adrenalin Receptors in Hearts

Previously, Northern blot analysis onAsic1a,Asic1b,Asic2,Asic4,Trpv1, andTrpv2 genes was done inAsic3
−/− mice to determine whether theAsic3 null mutation interferes with the expression of members of the ASIC and TRPV gene families. Our results indicate that no compensatory changes of other ASIC subtypes and TRPV genes occurred in DRG ofAsic3
−/− mice [23]. We next needed to determine whether gene compensation in the heart accounted for the abnormal cardiac autonomic regulation and isoproterenol response inAsic3
−/− mice. Because muscarinic acetylcholine receptors and beta-adrenoceptors are responsible for autonomic activity, we compared their expression in the heart ofAsic3
−/− andAsic3
+/+ mice. The expression ofM1,M2, andM4, as well asadrb1,adrb2, andadrb3, did not significantly differ between the genotypes (Figure 3(c)). The expression ofM3 andM5 was not detectable in hearts ofAsic3
−/− orAsic3
+/+ mice. We further verified a similar protein expression ofadrb2 andM2 in hearts of the two genotypes (Figure 3(d)). Therefore, gene compensation was not found in theAsic3
−/− mice and these results support our hypothesis that ASIC3 has its unique role in cardiac autonomic regulation.


## 4. Discussion

The null mutation ofAsic3 in mice in our study resulted in imbalanced autonomic regulation with decreased sympathetic function.Asic3
−/− mice showed subtle cardiovascular changes at baseline condition, with no obviously structural or functional anomaly and only lower ratios of LF power spectral density thanAsic3
+/+ mice. However, under stress,Asic3
−/− mice showed significantly lower blood pressure thanAsic3
+/+ mice and a maladaptive autonomic response when an ischemic stress was introduced with injection of isoproterenol. Because deletion ofAsic3 produced no obvious gene compensation of the adrenergic and cholinergic receptors in hearts, the disturbed cardiac function inAsic3
−/− mice might have a sensory neuron origin, with disrupted interaction between ASIC3 and other proton-sensing channels or receptors [29–32].The dominant expression ofAsic3 in sympathetic than parasympathetic afferent neurons provides molecular support for the disproportionate autonomic compensation ofAsic3
−/− mice. Our present study also provided results consistent with the rationale that gene expression of ion channels and receptors fundamentally differs between sensory neurons of dorsal root and nodose ganglia [33]. Previous studies show that ASIC3 in sensory afferents is involved in not only acid sensing but also mechanic and metabolic sensing [34–38]. Thus, deletion ofAsic3 would disturb the animal’s autonomic regulation during rest (reflecting mechanic and metabolic sensing) and loss of appropriate sympathetic afferent response under external stress (reflecting mechanic, metabolic, and acid sensing). Although ASIC3 has been implicated in modulating pain sensation because of its dominant location in the nociceptive sensory pathway, our studies unraveled an important role for ASIC3 in regulating the cardiac autonomic nervous system through altering inputs from cardiac sympathetic afferents, in addition to the conventional baroreceptors in the great vessels or the chemoreceptors in the carotid body [39].Sympathetic afferents have larger acid-evoked currents than parasympathetic afferents [17]. Accordingly, our PCR data showed sympathetic sensory neurons with higherAsic3 expression than parasympathetic sensory neurons (Figure 3(a)), which implies that sympathetic afferents are more sensitive to lactic acid acidosis. During exercise and stress, lactate and ATP are released [40, 41], and these two substances can potentiate ASIC3 [42, 43], as well as adaptive responses [44–47], so it is possible that ASIC3 is involved in adaptive reflexes. Since ASIC3 is mostly present in afferents related to sympathetic (DRG) rather than parasympathetic (nodose ganglia) stimulation, this finding agrees with the results of less cardiovascular sympathetic stimulation inAsic3
−/− mice.A previous study has shown that ASIC2 also contributes to autonomic regulation. Lu et al. reported that consciousAsic2 null (Asic2
−/−) mice developed hypertension and a decreased gain of the baroreflex [48]. A predominance of ASIC2 expression over other ASIC subtypes in nodose ganglia was also reported. In contrast toAsic3
−/− mice, which is presenting a phenotype of decreased sympathetic function,Asic2
−/− mice had exaggerated sympathetic and depressed parasympathetic control of the circulation. Accumulating evidence has shown that ASIC2 assembles with ASIC3 to form functional heteromeric channels, especially in cardiac sensory neurons [21, 29, 48]. Besides, our previous study also suggests that ASIC3 of nodose ganglia plays a role in low-threshold baroreceptor in regulating blood volume homeostasis [36]. Therefore, deleting either ASIC2 or ASIC3 will disturb the assembling of heteromeric ASIC2/3 channel, which might play a role in autonomic regulation [38].


## 5. Conclusions

We provided anin vivo evidence for ASIC3 in regulating cardiac autonomic function, whereby loss of ASIC3 alters the normal physiological response to ischemic stimuli, which reveals new implications for therapy in autonomic nervous system-related cardiovascular diseases. A previous clinical study also described poorer long-term outcomes for patients with silent myocardial ischemia than for those with symptomatic ischemia during dobutamine stress echocardiography [49]; implying loss of normal cardiac sensory input, such as ASIC3 or TRPV1, may have important clinical implication. Therefore, future studies involvingAsic3
−/− mice as a model for acid-evoked reflex loop during angina would provide valuable and informative clues to the therapeutic strategies for patients with cardiac ischemia.



---

*Source: 709159-2014-04-03.xml*